First Bancorp’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-2,379
Closed -$207K 134
2025
Q2
$207K Buy
+2,379
New +$202K 0.12% 124
2024
Q2
Sell
-2,710
Closed -$236K 121
2024
Q1
$236K Sell
2,710
-158
-6% -$13.5K 0.18% 104
2023
Q4
$236K Sell
2,868
-155
-5% -$11.8K 0.19% 100
2023
Q3
$237K Hold
3,023
0.21% 97
2023
Q2
$266K Hold
3,023
0.22% 90
2023
Q1
$244K Hold
3,023
0.21% 99
2022
Q4
$235K Sell
3,023
-242
-7% -$19.6K 0.2% 103
2022
Q3
$264K Buy
3,265
+95
+3% +$8.54K 0.24% 86
2022
Q2
$285K Sell
3,170
-57
-2% -$5.78K 0.27% 84
2022
Q1
$358K Hold
3,227
0.33% 63
2021
Q4
$334K Buy
3,227
+62
+2% +$7.18K 0.29% 68
2021
Q3
$397K Buy
+3,165
New +$410K 0.38% 56
2021
Q1
$379K Buy
+3,210
New +$376K 0.37% 57

Other funds holding MDT

First Bancorp's MDT Position: Q3 2025 in Review

First Bancorp sold out of Medtronic (MDT) in Q3 2025, closing a stake of 2,379 shares — an estimated $207K sold.

First Bancorp first reported a position in MDT in Q1 2021 and held it in 13 quarters. The position peaked at $397K in Q3 2021. 2,170 funds tracked by Wall St. Rank hold MDT as of Q3 2025.

  • First Bancorp reported no remaining Medtronic position as of Q3 2025 after selling out during the quarter.
  • First Bancorp sold 2,379 Medtronic shares in Q3 2025, an estimated $207K.
  • First Bancorp first reported a position in Medtronic in Q1 2021 and held it in 13 quarters.
  • First Bancorp's Medtronic position peaked at $397K in Q3 2021.
  • 2,170 funds tracked by Wall St. Rank held Medtronic as of Q3 2025.

Based on First Bancorp's 13F filing for Q3 2025, filed 23 Oct 2025.